| Description | Tesnatilimab is a potent humanized IgG4 monoclonal antibody that binds to the immune-activating receptor NKG2D. Tesnatilimab has potential immunomodulatory and anti-inflammatory activity and can be used to study active ulcerative colitis. |
| Synonyms | IPH-23XX, JNJ-64304500, JNJ 4500 |
| molecular weight | N/A |
| CAS | 2242758-08-1 |
| Storage | store at low temperature | store at -80°C |
| References | 1. Kasper Vadstrup, et al. Anti-NKG2D mAb: A New Treatment for Crohn's Disease? Int J Mol Sci. 2017 Sep 16;18(9):1997. |